Alok Sonig is executive vice president and group president, Pharmaceuticals.
He was appointed to his new role leading Pharmaceuticals in 2023 after serving as president since 2022.
Sonig joined Baxter in 2022 from Lupin, Inc., where he served as U.S. CEO and Global Head of R&D and Biosimilars. He brings more than 25 years of experience in the life sciences industry. Prior to Lupin, Inc., Sonig served as CEO of Developed Markets (U.S., Canada, Europe and Japan) at Dr. Reddy's Laboratories. He also spent more than 15 years at Bristol Myers Squibb, where he held several positions of increasing responsibility in general management, global strategy and marketing.
Sonig previously served as chairman of the board of the Association for Accessible Medicines and is currently an advisory board member for the Kogod School of Business, American University. He received his bachelor's degree in engineering from Punjab Engineering College in India and a master's degree in business administration from American University.